Novo Holdings A/S → Galecto, Inc. DMRA

Stake: 7.60% Shares: 99,913 CUSIP: 36322Q107 Class: Common Stock, par value $0.00001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 2.46

827,221 shares short · +93.4% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $2.51M

Point72 Asset Mgmt

Other Filings by Novo Holdings A/S

Filed	Form	Issuer	Stake	Shares
2024-01-02	SC	Rallybio Corp RLYB	—	—	view →
2018-02-26	SC	Ra Pharmaceuticals, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →